July 17, 2009
Our STN: BL 125020/1163
Attention: Nancy R. Kavanaugh, Ph.D.
One MedImmune Way
Gaithersburg, MD 20878
Dear Dr. Kavanaugh:
We have approved your request to supplement your biologics license application for Influenza Virus Vaccine Live, Intranasal (FluMist®), to include the 2009-2010 United States formulation.
Please note that the use of updated labeling for marketing your product is being approved under STN 125020/1086. We will include the information contained in the above-referenced supplement in your Biologics License Application file.
Jerry P. Weir, Ph.D.
Division of Viral Products
Office of Vaccines Research and Review
Center for Biologics Evaluation and Research